Solvay Stock: Shares Break Technical Resistance Following Strong Annual Results
Solvay's stock made significant progress this Thursday, February 26, driven by the announcement of its 2025 annual results and a strategic adjustment in its industrial capacities. The stock is trading at 28.64 euros, up 2.36% from the previous day, and has gained nearly 5% over seven days. This momentum comes as the Belgian chemical company revealed on Monday accounts considered resilient in a challenging industry context.
Annual Financial Performance and Strategic Adjustments
Solvay published its annual accounts for 2025 on February 24, reporting a robust generation of free cash flow despite an unfavorable market environment. The Belgian chemical group has managed to preserve a significant EBITDA margin, even as global demand remains constrained by geopolitical uncertainties and the persistent weakness of certain industrial outlets. Concurrently, Solvay announced a reduction in its soda ash production capacity at the Torrelavega site in Spain the day before. This decision addresses a global supply surplus and high energy costs impacting the competitiveness of European facilities. The next key dates on the calendar are the publication of the first quarter 2026 results, scheduled for May 7, followed by the annual general meeting set for May 12. Following these announcements, KBC Securities issued a 'hold' recommendation on the stock on February 24, without specifying a price target. This assessment reflects a cautious stance regarding the group's valuation in the current chemical sector context.
Technical Analysis of Stock Movement
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
You're in — subscription confirmed!
Your first edition is on its way. Check your spam folder and add us to your contacts.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
Gratuit · chaque matin
Ne ratez plus rien sur vos actions
La tendance derrière les cours. L'essentiel des valeurs Euronext en quelques minutes.
📈les valeurs en mouvement, sur la durée
🎯les objectifs d'analystes qui évoluent
📰les actualités qui font bouger les cours
tendance · 6 séances
✓ C'est fait, vous êtes inscrit !
Votre première édition arrive bientôt. Pensez à vérifier vos spams.
Une erreur est survenue.
CAC 40 · SBF 120 · données indicatives · aucun conseil en investissement · désinscription à tout moment.
From a technical perspective, today's session marks a significant event: Solvay's share price has reached 28.64 euros, surpassing the resistance level identified at 28.50 euros. This breakthrough is a bullish signal in the short term and is part of a recovery movement that began in recent weeks. The stock is now trading above its 200-day moving average (27.80 euros) and well beyond its 50-day average (26.81 euros). The RSI, an indicator that measures the speed and magnitude of price changes, stands at 61, indicating a positive dynamic without signs of overheating. This level suggests that the recent progress still has room before reaching levels typically associated with overbuying. Despite this rebound, the stock's annualized performance remains negative at -7.1% over the year, highlighting the persistent pressures faced by the European chemical sector for several quarters.
Challenging market environment, excluding potential recovery measures from Sadara, updated guidance reflects Middle East impact
Risks mentioned
Middle East conflict impact of approximately €-25 million on underlying EBITDA in Q3 2026
Continued shutdown of the Peroxide plant at the Sadara complex in Jubail, Saudi Arabia accounted for €-15 million in Q3 2026
Challenging market environment affecting Group performance in Q3 2026
Opportunities identified
Joint venture contractual framework includes mechanisms designed to recover lost profitability from Sadara shutdown
Group exploring all available avenues to mitigate financial impact of shutdown
Transformation program and focus on cash generation and cost savings targets
Outlook / guidance
Expected EBITDA: 730 millions d'euros
Management commentary: In light of these developments, Solvay has reviewed its full-year 2026 guidance. Excluding potential revenue or recovery measures from Sadara for the remainder of 2026, the updated guidance is: Underlying EBITDA between €720 and €740 million
The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.
Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.